RE:Long Term InvestmentInteresting comments. Boy they are giving themselves lots of room for error. They say it COULD be a $15 stock in 3-5 years. Unlikely to break past previous highs in the short-term. What's their idea of short term? But fair enough to suggest the long game needs to be played with this one. Disappointed to see 5iResearch putting us in the category of 'COVID stocks'. That's worse than being a telehealth stock. They have some detailed numbers in previous research, so I would have thought they would not be putting us in this stupid category of COVID stocks. I doubt that in 3 to 5 years we will be referred to as a COVID stock. COVID has affected everyone so I suppose that in a sense every stock is a COVID stock.
If you look at our share price on March 1, 2020 just before the onset of the pandemic, officially, our share price was $1.50. Right now, interestingly, TDOC's share price is far below what it was on March 1, 2020. For sure we got a bump with COVID, but in my view it was an acceleration of the digital transformation in healthcare which was already underway. The idea that we would discard all the efficiencies that WELL health has created simply because the pandemic is winding down makes no sense to me, but that is the theory that many paid analysts have, which now apparently includes long time supporters 5iResearch.
These target prices from analysts are just that: targets, in other words, something they would aim for. They are certainly not to be relied on. But they are worth something, and the weight of their target depends on the depth of their analsis. Right now we have 7 analysts from respected institutions with a median "target" price of $12.00. Not something to rely on by itself, but not something to ignore either. Not often you see such a large discrepancy between current share price and target prices.